TRex Bio, Inc. went public at $14.00 a share
It sold 8,333,334 shares on Nasdaq Global Select Market under the ticker TRXB and raised $116.7 million before costs.
Final prospectus (424B4) filed October 9, 2026
The terms
-
Offered
8,333,334 shares
Checked
Source
“We are selling 8,333,334 shares of our common stock.”
A model read this, and code confirmed the quote appears in the filing. -
Price per share
$14.00
Checked
Source
“The initial public offering price is $14.00 per share.”
A model read this, and code confirmed the quote appears in the filing. -
Raised
$116,666,676before fees and costs
Checked
Source and check
Shares × price = 8,333,334 × $14.00 = $116,666,676. They match.
“Initial public offering price | $14.00 | $116,666,676”
A model read this, and code confirmed the quote appears in the filing. -
Bank fee
$8,166,667$0.98 a share, 7.0% of the raise
Checked
Source
“Underwriting discounts and commissions(1) | $0.98 | $8,166,667”
A model read this, and code confirmed the quote appears in the filing. -
Company receives first
$108,500,009before other costs
Checked
Source and check
Raised − bank fee = $116,666,676 − $8,166,667 = $108,500,009. They match.
“Proceeds, before expenses, to us | $13.02 | $108,500,009”
A model read this, and code confirmed the quote appears in the filing. -
Lead banks
J.P. Morgan, Evercore ISI, Cantor, Stifel, Wedbush PacGrow
From the prospectus
Source
“J.P. Morgan | Evercore ISI | Cantor | Stifel | Wedbush PacGrow”
A model read this, and code confirmed the quote appears in the filing. -
Trades as
TRXB on Nasdaq Global Select Market
Checked
Source
“Our common stock has been approved for listing on The Nasdaq Global Select Market (“Nasdaq”) under the symbol “TRXB.””
A model read this, and code confirmed the quote appears in the filing. -
Extra for the banks
Up to 1,250,000 sharesan option the banks may use
From the prospectus
Source
“The underwriters may also exercise their option to purchase up to an additional 1,250,000 shares from us, at the initial public offering price, less underwriting discounts and commissions, for 30 days after the date of this prospectus.”
A model read this, and code confirmed the quote appears in the filing. - Final prospectus filed October 9, 2026
Not investment advice.Open the filing on SEC.gov
Where the money goes first
The banks take their fee before the company sees the money.
Who owns the company after the IPO
From the prospectus 8,333,334 of 27,445,682 shares outstanding after the offering (30.4%).
Where TRex Bio, Inc. sits among the last 12 months
Each bubble is one IPO. Bigger and higher means more money raised. The scale grows by ten times at each line.
New to these terms? How to read an IPO.